RESEARCH SUPPORT, N.I.H., EXTRAMURAL
Rethinking First-Line Immunosuppression for Idiopathic FSGS.Jordana B Cohen, Jonathan J Hogan
No abstract text is available yet for this article.
Full text links
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app